Propiedad y actividad de insiders de Alterity Therapeutics Limited (ATHE): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.85 |
| Capitalización | $65M |
| Bolsa | NASDAQ |
| País | AU |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-31 | Marks Peter Ashley | P-Purchase | 47,620 | $24K |
| 2026-08-31 | Marks Peter Ashley | P-Purchase | 47,620 | $24K |
| 2026-08-31 | Stamler David Allen | P-Purchase | 47,620 | $24K |
| 2026-06-15 | Babarczy Julian Michael | A-Award | 2,000,000 | $2.0M |
| 2026-06-15 | Gozlan Lawrence Bernard | A-Award | 1,000,000 | $1.0M |
| 2026-04-17 | Cunningham Ann Michelle | |||
| 2026-04-15 | Stamler David Allen | |||
| 2026-04-15 | Stamler David Allen | |||
| 2026-04-15 | Stamler David Allen | 1,515,152 | $42K | |
| 2026-04-15 | Stamler David Allen | 2,380,952 | $24K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $21.9M | $15.2M | $14.4M | $9.2M | $28.1M | $34.8M | $15.8M | $12.6M | $33.2M | $37.3M |
| Inversiones a Corto | $43988 | $9514 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M | 0 |
| Cuentas por Cobrar | $3.0M | $3.2M | $4.8M | $61321 | $4.1M | $4.7M | $8.6M | $4.0M | $3.9M | $7.7M |
| Inventario | $241625 | $256821 | $621737 | $567884 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.3M | $18.7M | $19.9M | $13.2M | $33.5M | $41.1M | $27.0M | $19.0M | $45.9M | $45.8M |
| Inmovilizado Material | $30815 | $71422 | $48748 | $71369 | $96808 | $218522 | $268863 | $186883 | $155174 | $190570 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25.3M | $18.7M | $19.9M | $13.3M | $33.6M | $41.4M | $27.3M | $19.2M | $46.0M | $46.0M |
| Cuentas por Pagar | $65049 | $1.3M | $1.7M | $954033 | $1.4M | $2.6M | $1.7M | $581137 | $538276 | $1.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $55177 |
| Pasivos Corrientes | $1.6M | $2.6M | $3.3M | $2.7M | $3.1M | $5.8M | $4.4M | $5.4M | $3.5M | $3.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $2.6M | $3.4M | $2.8M | $3.1M | $5.9M | $4.5M | $5.4M | $3.6M | $3.3M |
| Reservas | -$122.6M | -$129.6M | -$141.2M | -$151.0M | -$169.7M | -$181.9M | -$195.1M | -$214.2M | -$225.9M | -$245.6M |
| Patrimonio Neto | $23.7M | $16.1M | $16.6M | $10.5M | $30.5M | $35.5M | $22.8M | $13.8M | $42.4M | $42.7M |
| Deuda Total | 0 | 0 | 0 | $33747 | $65649 | $117489 | $210384 | $159045 | $155457 | $193475 |
| Deuda Neta | -$21.9M | -$15.2M | -$14.4M | -$9.2M | -$28.0M | -$34.7M | -$15.6M | -$12.5M | -$40.5M | -$37.1M |
| Capital Circulante | $23.7M | $16.0M | $16.5M | $10.5M | $30.4M | $35.3M | $22.7M | $13.7M | $42.3M | $42.7M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 14.52 |
Rentabilidad
| Rentabilidad sobre capital | -53.57% |
| Rentabilidad sobre capital invertido | -56.35% |
| Rentabilidad sobre activos | -49.74% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ANVS · BTAI · DYAI · EVAX · GBIO · IGC · LIMN
Explorar sector: Healthcare · Biotechnology
Más secciones de ATHE: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones